|Have Questions?||Leave a Message or Start an on-line Chat|
The STAT3 recombinant monoclonal antibody is meticulously produced to ensure its exceptional quality and specificity. The process begins with the isolation of B cells from the spleen of an immunized animal, where the synthesized peptide derived from human STAT3 is used as the immunogen. RNA is extracted from the B cells and converted into cDNA through reverse transcription. The STAT3 antibody genes are amplified using specific primers targeting the antibody constant regions and inserted into an expression vector. This vector is then transfected into host cells to enable the production of the STAT3 recombinant monoclonal antibody. After a period of cell culture, the antibody is harvested from the cell culture supernatant and purified with great care using affinity chromatography. This meticulous purification process ensures the obtainment of a highly purified form of the STAT3 recombinant monoclonal antibody, suitable for various applications. Rigorous characterization assays, including ELISA and IHC analysis, are conducted to validate the antibody's specificity and functionality in detecting human STAT3 protein. The rigorous production process guarantees the development of a reliable and effective STAT3 recombinant monoclonal antibody, making it an invaluable tool in diverse research related to STAT3.
There are currently no reviews for this product.